Engineering Immune Organoids to Study Pediatric Cancer
To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)
Brain Tumor|Kidney Tumor|Neuroblastoma|Sarcoma
PROCEDURE: Skin biopsy|PROCEDURE: Fresh tumor sample|BIOLOGICAL: Blood sample|PROCEDURE: Healthy tissue from the tumor|PROCEDURE: Spinal cerebrospinal fluid (SCF)
Proportion of viable and exploitable immune organoids with engrafted tumor cells, until 5 years after enrolment
To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)